Search details
1.
Notch pathway regulates osimertinib drug-tolerant persistence in EGFR-mutated non-small-cell lung cancer.
Cancer Sci
; 114(4): 1635-1650, 2023 Apr.
Article
in English
| MEDLINE | ID: mdl-36411521
2.
Effects of obesity on CC16 and their potential role in overweight/obese asthma.
Respir Res
; 23(1): 174, 2022 Jun 29.
Article
in English
| MEDLINE | ID: mdl-35768822
3.
Phase II study of carboplatin-paclitaxel alone or with bevacizumab in advanced sarcomatoid carcinoma of the lung: HOT1201/NEJ024.
Int J Clin Oncol
; 27(4): 676-683, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35092535
4.
Risk of bleeding associated with transbronchial biopsy using flexible bronchoscopy in patients with echocardiographic or chest CT evidence of pulmonary hypertension.
BMC Pulm Med
; 22(1): 449, 2022 Nov 28.
Article
in English
| MEDLINE | ID: mdl-36443763
5.
D-2-hydroxyglutarate produced by mutant IDH2 causes cardiomyopathy and neurodegeneration in mice.
Genes Dev
; 28(5): 479-90, 2014 Mar 01.
Article
in English
| MEDLINE | ID: mdl-24589777
6.
Bromodomain and extraterminal domain inhibition synergizes with WEE1-inhibitor AZD1775 effect by impairing nonhomologous end joining and enhancing DNA damage in nonsmall cell lung cancer.
Int J Cancer
; 146(4): 1114-1124, 2020 02 15.
Article
in English
| MEDLINE | ID: mdl-31199520
7.
DLL3 regulates the migration and invasion of small cell lung cancer by modulating Snail.
Cancer Sci
; 110(5): 1599-1608, 2019 May.
Article
in English
| MEDLINE | ID: mdl-30874360
8.
Combined antitumor effect of γ-secretase inhibitor and ABT-737 in Notch-expressing non-small cell lung cancer.
Int J Clin Oncol
; 22(2): 257-268, 2017 Apr.
Article
in English
| MEDLINE | ID: mdl-27816990
9.
CD133 expression: a potential prognostic marker for non-small cell lung cancers.
Int J Clin Oncol
; 19(2): 254-9, 2014 Apr.
Article
in English
| MEDLINE | ID: mdl-23479121
10.
A phase II study of amrubicin as a third-line or fourth-line chemotherapy for patients with non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0901.
Oncologist
; 18(4): 439-45, 2013.
Article
in English
| MEDLINE | ID: mdl-23442308
11.
Gefitinib-induced Myositis: A Novel Case Report.
Yakugaku Zasshi
; 143(7): 617-620, 2023.
Article
in English
| MEDLINE | ID: mdl-37394456
12.
Inhibition of non-homologous end joining mitigates paclitaxel resistance resulting from mitotic slippage in non-small cell lung cancer.
Cell Cycle
; 22(17): 1854-1864, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37592765
13.
The peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based test for epidermal growth factor receptor mutations in bronchoscopic cytological specimens of non-small cell lung cancer.
Oncology
; 82(6): 341-6, 2012.
Article
in English
| MEDLINE | ID: mdl-22677909
14.
Expression of Bim, Noxa, and Puma in non-small cell lung cancer.
BMC Cancer
; 12: 286, 2012 Jul 12.
Article
in English
| MEDLINE | ID: mdl-22788963
15.
Phase II study of irinotecan plus S-1 combination for previously untreated advanced non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0601.
Oncology
; 81(2): 84-90, 2011.
Article
in English
| MEDLINE | ID: mdl-21968255
16.
Elevated serum CYFRA 21-1 level as a diagnostic marker for thymic carcinoma.
Thorac Cancer
; 12(21): 2933-2942, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34581013
17.
Randomized phase 2 study comparing irinotecan versus amrubicin as maintenance therapy after first-line induction therapy for extensive disease small cell lung cancer (HOT1401/NJLCG1401).
Thorac Cancer
; 12(14): 2113-2121, 2021 07.
Article
in English
| MEDLINE | ID: mdl-34076966
18.
A case of radio-insensitive SMARCA4-deficient thoracic undifferentiated carcinoma with severe right heart failure.
Respir Med Case Rep
; 32: 101364, 2021.
Article
in English
| MEDLINE | ID: mdl-33665078
19.
CD8+ tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection.
Cancer Immunol Immunother
; 59(10): 1543-9, 2010 Oct.
Article
in English
| MEDLINE | ID: mdl-20567822
20.
Nivolumab-induced immune thrombocytopenia in a patient with malignant pleural mesothelioma.
Respir Med Case Rep
; 31: 101170, 2020.
Article
in English
| MEDLINE | ID: mdl-32714828